GCP‐2, via phosphorylation of the transcription factor CREB at serine 133, regulates cell cycle control and glycolysis‐enhancing genes in melanoma cell lines, thereby promoting oncogenic properties in vitro and in vivo in murine melanoma models. This evidence concerns the gene CXCL6 and melanoma.